Logo

The US FDA Approved Recor Medical and Otsuka Medical Devices’ Paradise Ultrasound Renal Denervation System for Hypertension

Share this

The US FDA Approved Recor Medical and Otsuka Medical Devices’ Paradise Ultrasound Renal Denervation System for Hypertension

Shots:

  • The approval was based on the results from the (RADIANCE II) trial evaluating the safety & effectiveness of the Paradise system in patients with hypertension. The results from the trial were published in JAMA”
  • The (RADIANCE II) clinical trial is a part of Recor’s RADIANCE global program which incl. 3 independent trials in 500 patients incl. (RADIANCE II) & (RADIANCE-HTN SOLO) for mild-moderate hypertension & (RADIANCE-HTN TRIO) for resistant hypertension
  • The Paradise system is an ultrasound-based RDN technology that lowers blood pressure by denervating sympathetic nerves around renal arteries, reducing hypertension, and features a HydroCooling system for sterile water circulation to help protect the renal artery wall

Ref: Businesswire | Image: ReCor Medical

Related News:- ReCor Medical Presents RADIANCE Clinical Trial Program Results of Paradise Ultrasound Renal Denervation System for Hypertension at AHA 2022 

PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com

Click here to­ read the full press release 

Shivani Chandra

Shivani was a content writer at PharmaShots. She has a keen interest in recent innovations in the life sciences industry. She was covering news related to Product approvals, clinical trial results, and updates. We can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions